Heather Deixler counsels public and private companies operating in the healthcare industry on transactional and regulatory matters.

Ms. Deixler focuses on the intersection of healthcare, life sciences, and technology. She advises a wide range of public and private companies, including healthcare providers and healthcare systems, digital health, e-commerce, medical device, therapeutics, genetics, and bioscience companies on cutting-edge matters and initiatives including:

  • Innovative healthcare delivery systems, including value-based enterprises, clinically integrated networks, IPAs, Medicare ACOs, and other value-based payment programs
  • AI / machine learning solutions
  • Data rights
  • Data use and protection
  • Genomic privacy
  • General data privacy and security matters, including data privacy and security policies and procedures, and online privacy policies and terms of service
  • Information blocking and interoperability
  • Real-world data / evidence generation
  • Data breach response

Ms. Deixler is a Certified Information Privacy Professional (CIPP/US and CIPP/E) and focuses on all aspects of digital health, including advising clients on various laws and regulations governing healthcare regulatory issues as well as data privacy and consumer protection, including:

  • Stark Law, the Federal Anti-Kickback Statute, and state law equivalents
  • Health Insurance Portability and Accountability Act (HIPAA)
  • California Consumer Privacy Act (CCPA) and California Privacy Rights Act (CPRA)
  • Children’s Online Privacy Protection Act (COPPA)
  • Federal Trade Commission Act
  • Telemarketing laws
  • Self-regulatory and online behavioral advertising guidelines

Ms. Deixler previously served as an Adjunct Professor in the Health Law LLM program at the University of Washington School of Law. Prior to attending law school, she worked as a research technician in a neurophysiology laboratory in Dijon, France, and as a clinical research assistant at the Beth Israel Deaconess Medical Center in Boston.

Ms. Deixler’s representative clients include:

  • 10x Genomics
  • Adventist Health
  • ArchiMed
  • Ascendis Pharma
  • Cerner Corporation
  • Clarify Health
  • CooperCompanies
  • Corcept Therapeutics
  • Crossover Health
  • Cryos
  • Curative
  • Decoded Health
  • DoorDash
  • eFFECTOR Therapeutics
  • Ginkgo Bioworks
  • GoodCell
  • GoodRx Holdings
  • Headspace
  • Imago BioSciences
  • Johnson & Johnson
  • Nano X Imaging
  • Noom
  • NorthBay Healthcare Group
  • Oova
  • Owlet Baby Care
  • Overjet
  • P3 Health Partners
  • Pendulum Therapeutics
  • PharMerica
  • pMD
  • Preventice Solutions
  • Revival Health
  • Revolution Medicines
  • Rubicon Founders
  • Seres Therapeutics
  • Summerbio
  • Treace Medical Concepts
  • Varian Medical Systems

Thought Leadership

Ms. Deixler writes and speaks frequently on a variety of healthcare and data privacy topics, including the use of AI/ML in healthcare and the recently finalized Information Blocking and Interoperability Rules.

A selection of her recent thought leadership includes:


  • “Personalizing Digital Health Through Adaptive Patient-Focused Digital Front Doors,” moderator for panel at HealthIMPACT Fall Forum (Nov 2021)
  • “Information Blocking Is Here: A Deep Dive into the Practical Application of the ONC Rule after One Year, FAQs, and Unanswered Questions,” co-panelist for AHLA Webinar (May 2021)
  • “Interoperability and Information Blocking: CMS and ONC Rules Implementing the 21st Century Cures Act,” co-panelist for AHLA Webinar (Nov 2020)
  • “Contagion: Battling COVID-19 and Future Pandemics with AI and Robotics,” moderator for panel at ABA AI and Robotics National Institute (Oct 2020)
  • “Whose Data is it Anyway? Privacy, Patient Engagement, HIPAA and Beyond,” co-presenter with Shannon B. Hartsfield, ABA Virtual Emerging Issues in Healthcare Law Conference (Apr 2020)
  • “COVID-19: Considerations for Healthcare Facilities Responding to the Pandemic,” co-panelist for ABA Webinar (Mar 2020)


  • “Will You Share My Data, Please?,” co-authored with Ty Kayam, The SciTech Lawyer, Vol. 17, No. 4, (June 2021)
  • “Chatbots Meet COVID-19, Why Lawyers Should Pay Attention,” co-authored with Karen Silverman, The SciTech Lawyer, Vol. 17. No 1, Fall 2020, AI and Healthcare (Sep 2020)
  • “HHS’ Sweeping Interoperability and Information Blocking Final Rules Bring Patient Health Data Access into the 21st Century,” AHLA Weekly Alert (Mar 2020)

Bar Qualification

  • California


  • JD, University of Washington School of Law, 2007
  • MPhil, University of Cambridge, 2000
  • BA, University of Pennsylvania, 1998

Languages Spoken

  • English
  • French